z-logo
open-access-imgOpen Access
COVID-19 e hipertension arterial: ¿existe evidencia para suspender antagonista sistema renina angiotensina?
Author(s) -
Ignacio Villanueva Bendek,
Roberto Ramírez,
Juan Montejo Hernández,
Joaquín Rodelo Ceballos,
Luis Puello González,
María Vélez-Verbel,
Laura Gómez Franco
Publication year - 2020
Publication title -
revista colombiana de nefrología
Language(s) - Portuguese
Resource type - Journals
eISSN - 2500-5006
pISSN - 2389-7708
DOI - 10.22265/acnef.7.supl.2.405
Subject(s) - medicine , renin–angiotensin system , covid-19 , angiotensin converting enzyme 2 , disease , angiotensin receptor blockers , pathophysiology , receptor , angiotensin ii , diabetes mellitus , coronavirus , bioinformatics , pharmacology , endocrinology , virology , blood pressure , biology , infectious disease (medical specialty) , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom